Interestingly, the glioma TME-generated CCL2 mediates the recruitment of inhibitory CCR2+ monocyte MDSCs and Tregs (91), while mIDH glioma has a reduced CCL2 expression (76). Here, CCL2 is linked to central nervous system cancer.